Amplify YieldShares Oil Hedged MLP Income ETF (AMLX): Price and Financial Metrics ETF

Amplify YieldShares Oil Hedged MLP Income ETF (AMLX): $1.83

0.00 (0.00%)

POWR Rating

Component Grades

Buy & Hold

F

Peer

D

Add AMLX to Watchlist
Sign Up

Category: MLP ETFs

Category

C

Ranked


in category

AMLX Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market

Current price $1.83 52-week high $27.99
Prev. close $1.83 52-week low $1.70
Day low $1.81 Volume 1,222,800
Day high $1.87 Avg. volume 2,647,627
50-day MA $2.38 Dividend yield N/A
200-day MA $13.39

AMLX Stock Price Chart Interactive Chart >


Amplify YieldShares Oil Hedged MLP Income ETF (AMLX) ETF Bio


The investment objective of the Amplify YieldShares Oil Hedged MLP Income ETF is to selects its components from the Oil Hedged MLP Index with the intention of outperforming the index. It also holds short positions in WTI crude oil futures to limit the fund’s correlation with oil prices.

AMLX ETF Info

Issuer
Expense Ratio %
Asset Class
Sector MLP ETFs
Assets Under Management (AUM) N/A
Net Asset Value (NAV) $0.00
Options? No
Total Holdings N/A

AMLX Top Holdings

Symbol Company % of Total

Latest AMLX News From Around the Web

Below are the latest news stories about AMYLYX PHARMACEUTICALS INC that investors may wish to consider to help them evaluate AMLX as an investment opportunity.

Is Amylyx (AMLX) Stock a Solid Choice Right Now?

Amylyx (AMLX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Yahoo | December 26, 2023

Amylyx Pharmaceuticals Announces First Participant Dosed in the Global Phase 3 ORION Study of AMX0035 in Progressive Supranuclear Palsy (PSP)

CAMBRIDGE, Mass., December 22, 2023--Amylyx Pharmaceuticals Announces First Participant Dosed in the Global Phase 3 ORION Study of AMX0035 in Progressive Supranuclear Palsy (PSP)

Yahoo | December 22, 2023

Implied Volatility Surging for Amylyx (AMLX) Stock Options

Investors need to pay close attention to Amylyx (AMLX) stock based on the movements in the options market lately.

Yahoo | December 11, 2023

Amylyx Pharmaceuticals Announces Publication of Data Showing the Effect of AMX0035 on Plasma Neuroinflammatory Biomarkers in ALS

CAMBRIDGE, Mass., December 04, 2023--Amylyx Pharmaceuticals Announces Publication of Data Showing the Effect of AMX0035 on Plasma Neuroinflammatory Biomarkers in ALS

Yahoo | December 4, 2023

Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., November 29, 2023--Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo | November 29, 2023

Read More 'AMLX' Stories Here

AMLX Price Returns

1-mo -2.14%
3-mo N/A
6-mo -85.52%
1-year -93.15%
3-year N/A
5-year N/A
YTD -87.57%
2023 -60.16%
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!